D. Leach

发表

Enhancement of Antitumor Immunity by CTLA-4 Blockade

J. Allison, M. Krummel, D. Leach, 1996, Science.

Responses in HER-2 Transgenic Mice Protective and Therapeutic Antitumor Potent Th Cell Epitopes Induce Distinct HER-2 DNA and Protein Vaccines Containing

Mouritsen, D. Leach, A. Gautam, 2003 .

HER-2 DNA and Protein Vaccines Containing Potent Th Cell Epitopes Induce Distinct Protective and Therapeutic Antitumor Responses in HER-2 Transgenic Mice

D. Leach, S. Mouritsen, A. Gautam, 2003, The Journal of Immunology.

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

J. Allison, D. Leach, A. Hurwitz, 1998, Proceedings of the National Academy of Sciences of the United States of America.

GrowthSelf-Reactive CTL and Inhibits Tumor Linked Foreign T-Cell Help Activates

J. Rygaard, D. Leach, L. Steinaa, 2005 .

Linked Foreign T-Cell Help Activates Self-Reactive CTL and Inhibits Tumor Growth1

J. Rygaard, D. Leach, L. Steinaa, 2005, The Journal of Immunology.

Perspectives on the development of a therapeutic HER-2 cancer vaccine.

D. Leach, V. Renard, 2007, Vaccine.

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

J. Allison, D. Leach, A. Hurwitz, 1995, Current opinion in immunology.

Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.

D. Leach, G. Callahan, 1995, Journal of immunology.

Manipulation of T Cell Activation in the Anti-Tumor Immune Response

J. Allison, D. Leach, A. Hurwitz, 1998 .

Lymphocyte alterations in zinc-deficient calves with lethal trait A46.

H. Ochs, J. Ellis, D. Leach, 1989, Veterinary immunology and immunopathology.

Persistent cryptosporidiosis in horses with severe combined immunodeficiency

D. Leach, L. Perryman, J. M. Bjorneby, 1991, Infection and immunity.

Tumor cells engineered to express major histocompatibility complex class II molecules induce T helper cell-dependent responses that protect mice from normally lethal doses of unmodified tumor cells.

D. Leach, G. Callahan, 1996, Cancer detection and prevention.

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

J. Allison, D. Leach, A. Hurwitz, 1998, Proceedings of the National Academy of Sciences of the United States of America.